Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-02-20

Clinical Trial Update: A Study to Determine if New Types of Malaria Vaccines Are Safe, Effective and Lead to Immunity in Kenyan Adults [Phase 2]

View source ↗

Summary

A Phase 2 malaria vaccine trial conducted in Kenyan adults has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Oxford | Conditions: Malaria,Falciparum | Phase 2 | Status: TERMINATED